| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 23.09. | iZafe Group AB: Dosell launches in Iceland through Lyfja and SKAND | 263 | GlobeNewswire (Europe) | iZafe Group AB (publ) today announces that Dosell is now commercially available in Iceland through the pharmacy chain Lyfja and local distribution partner SKAND. The launch marks the commercial activation... ► Artikel lesen | |
| IZAFE GROUP Aktie jetzt für 0€ handeln | |||||
| 16.09. | iZafe Group AB: Dosell wins new municipal contract under Adda's framework agreement - Mora, Orsa and Älvdalen | 211 | GlobeNewswire (Europe) | iZafe Group AB (publ) today announces that its wholly owned subsidiary Dosell AB has entered into an agreement with the municipalities of Mora, Orsa and Älvdalen after being selected as the winning... ► Artikel lesen | |
| 07.09. | iZafe Group AB: Monthly Letter August - Production Underway and Focus on Autumn Implementations | 289 | GlobeNewswire (Europe) | August, as is normally the case during the summer holiday period, was a quieter month in terms of new implementations. At the same time, production of the new batch of approximately 1,300 Dosell units... ► Artikel lesen | |
| 31.08. | iZafe Group AB: iZafe Group's interim report for the second quarter of 2026, April-June 2026 | 215 | GlobeNewswire (Europe) | iZafe Group AB (publ.) today presents its report for the second quarter of 2026, on August 31.
Financial Performance in SummaryThe Group's net sales for the quarter amounted to 2,639 (1,136) TSEK. Net... ► Artikel lesen | |
| 10.07. | iZafe Group AB: iZafe Group AB carries out the first partial payment for the acquisition of its Dutch subsidiary through a set-off issue of B shares | 253 | GlobeNewswire (Europe) | In September 2025, iZafe Group AB, reg. no. 556762-3391 ("iZafe" or the "Company"), acquired the Dutch company Thuisapparatuur Nederland B.V. ("TAN"). iZafe has today entered into an addendum agreement... ► Artikel lesen | |
| 07.07. | iZafe Group: June Monthly Letter - Strong Pipeline and Preparations for An Intensive Autumn | 368 | ACCESS Newswire | STOCKHOLM, SE / ACCESS Newswire / July 7, 2026 / iZafe Group (STO:IZAFE-B) - June was a month in which we continued to build on the increased activity we have seen during the spring. At the same time... ► Artikel lesen | |
| 26.06. | iZafe Group's CEO Transfers Shares Privately to Enable Participation in LTIP 2026:I | 398 | ACCESS Newswire | STOCKHOLM, SE / ACCESS Newswire / June 26, 2026 / iZafe Group (STO:IZAFE-B) - iZafe Group AB (publ.) announces that the company's CEO, Anders Segerström, has transferred 900,901 B shares in iZafe Group... ► Artikel lesen | |
| 08.06. | iZafe Group: May Monthly Letter: Continued Scaling and Increased Utilisation | 383 | ACCESS Newswire | STOCKHOLM, SE / ACCESS Newswire / June 8, 2026 / iZafe Group (STO:IZAFE-B) - May was a month in which we continued to build on the foundation established during the spring. Following the entry into... ► Artikel lesen | |
| 08.05. | iZafe Group: Monthly Letter April - Increased Activity and Growing Implementations | 730 | ACCESS Newswire | STOCKHOLM, SE / ACCESS Newswire / May 8, 2026 / iZafe Group (STO:IZAFE-B) - April was characterized by a high level of activity across several areas. We continue to see strong interest in Dosell, both... ► Artikel lesen | |
| 28.04. | iZafe Group Q1 Interim Report, January-March 2026 | 394 | ACCESS Newswire | STOCKHOLM, SE / ACCESS Newswire / April 28, 2026 / iZafe Group (STO:IZAFE-B) - iZafe Group AB (publ.) presents today, April 28th, its report for the first quarter.Financial Performance in SummaryThe... ► Artikel lesen | |
| 23.04. | iZafe Group: Dosell Awarded Contract with Västervik Municipality Regarding Medication Dispensing Devices | 340 | ACCESS Newswire | STOCKHOLM, SE / ACCESS Newswire / April 23, 2026 / iZafe Group (STO:IZAFE-B) - iZafe Group AB (publ) announces that its subsidiary Dosell AB, together with Atea Sverige AB, has been awarded a contract... ► Artikel lesen | |
| 13.04. | iZafe Group Achieves ISO/IEC 27001 Certification and Strengthens Its Position for International Expansion | 432 | ACCESS Newswire | STOCKHOLM, SE / ACCESS Newswire / April 13, 2026 / iZafe Group (STO:IZAFE-B) - iZafe Group AB (publ) today announces that the company has obtained certification according to the international ISO/IEC... ► Artikel lesen | |
| 10.04. | iZafe Group: Monthly Update March - ADDA in Effect and Preparations for the Next Growth Phase | 517 | ACCESS Newswire | STOCKHOLM, SE / ACCESS Newswire / April 10, 2026 / iZafe Group (STO:IZAFE-B) - March has been a month where several important milestones have been achieved for iZafe Group. The ADDA framework agreement... ► Artikel lesen | |
| 07.04. | iZafe Group: Dosell AB Awarded Contract with Region Jönköping County and its Municipalities | 459 | ACCESS Newswire | STOCKHOLM, SE / ACCESS Newswire / April 7, 2026 / iZafe Group AB (publ)(STO:IZAFE-B) today announces that its subsidiary Dosell AB has been awarded a sub-contract within Region Jönköping County's procurement... ► Artikel lesen | |
| 01.04. | iZafe Group: Dosell AB Granted European Patent in Data-Driven Medication Management | 389 | ACCESS Newswire | STOCKHOLM, SE / ACCESS Newswire / April 1, 2026 / iZafe Group (STO:IZAFE-B) - iZafe Group AB (publ) today announces that its subsidiary Dosell AB has been granted a European patent, EP4228584, titled... ► Artikel lesen | |
| 12.03. | iZafe Group: Dosell AB Signs Framework Agreement with Adda Following the End of the Appeal Period | 567 | ACCESS Newswire | STOCKHOLM, SWEDEN / ACCESS Newswire / March 12, 2026 / iZafe Group (STO:IZAFE-B) today announces that its subsidiary Dosell AB has signed a framework agreement with Adda Inköpscentral following the... ► Artikel lesen | |
| 12.03. | The observation status for iZafe Group AB is removed | 422 | GlobeNewswire | On February 17, 2026, the shares in iZafe Group AB (the "Company") were given observation status with reference to uncertainty in respect of the issuer's financial position.
On February 19, 2026... ► Artikel lesen | |
| 12.03. | Communiqué from the Extraordinary General Meeting of iZafe Group AB | 436 | ACCESS Newswire | STOCKHOLM, SE / ACCESS Newswire / March 12, 2026 / iZafe Group (STO:IZAFE-B) - An Extraordinary General Meeting was held in iZafe Group AB, reg. no. 556762-3391 (the "Company"), on 12 March 2026 at... ► Artikel lesen | |
| 12.03. | XFRA NEW INSTRUMENTS AVAILABLE ON 12.03.2026 | 1.159 | Xetra Newsboard | The following instruments on XETRA do have their first trading 12.03.2026 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 12.03.2026
Aktien
1 SGXE65286994 Baidu Inc. SDR
2 SE0002402701... ► Artikel lesen | |
| 09.03. | iZafe Group: Monthly Letter February - ADDA, Growth Capital and Preparations for Scaling | 759 | ACCESS Newswire | STOCKHOLM, SE / ACCESS Newswire / March 9, 2026 / iZafe Group (STO:IZAFE-B) - February has been a month where several important pieces have fallen into place for iZafe Group. We have been awarded a... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS | 43,635 | -0,38 % | Fresenius Kabi erhält Warnung von der US-Gesundheitsbehörde FDA | DJ Fresenius Kabi erhält Warnung von der US-Gesundheitsbehörde FDA
DOW JONES--Die Fresenius-Tochter Kabi hat einen Warnschuss von der US-Gesundheitsbehörde FDA erhalten. In dem am Dienstag veröffentlichten... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 37,860 | +0,66 % | JEFFERIES stuft Siemens Healthineers auf 'Buy' | NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat die Einstufung für Siemens Healthineers mit einem Kursziel von 50 Euro auf "Buy" belassen. Accela sei ein Quantensprung in der Strahlentherapie... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 39,550 | -0,33 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
| LIFESTANCE HEALTH GROUP | 11,830 | 0,00 % | LifeStance Health Group, Inc.: LifeStance Reports Strong Second Quarter 2026 Financial Results and Raises Full Year Outlook | SCOTTSDALE, Ariz., Aug. 06, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 60,27 | +0,03 % | BMO Capital reiterates Outperform on BrightSpring Health stock | ||
| BILLIONTOONE | 105,90 | 0,00 % | BillionToOne Appoints Ethan Dmitrovsky, MD, as Chief Medical Officer, Oncology, to Lead Medical Strategy for Northstar | Renowned physician-scientist, former Director of Frederick National Laboratory, and one of the nation's most accomplished leaders in oncology joins BillionToOne... ► Artikel lesen | |
| HEARTFLOW | 49,270 | -0,10 % | AI Cardiac Diagnostics Pioneer Sets HeartFlow (HTFL) for High-Margin Expansion | ||
| PROCEPT BIOROBOTICS | 17,160 | 0,00 % | PROCEPT BioRobotics Corp - 8-K, Current Report | ||
| ALIGNMENT HEALTHCARE | 7,945 | 0,00 % | Are Options Traders Betting on a Big Move in Alignment Healthcare Stock? | ||
| CARL ZEISS MEDITEC | 31,300 | +0,32 % | 12 Prozent bessere Leistung, 14 Prozent weniger Belastung: Warum ZEISS das Brillenglas neu denkt - und wo Rise Nano Optics ins Spiel kommt | ||
| QTREX QUANTUM | 1,100 | 0,00 % | QTREX Quantum Ltd.: QTREX Interconnect Independently Tested at 20 mK by a Leading Quantum Computing Company; Over 100 dB Channel Isolation, 60 dB Beyond the Market Leader | ||
| GENEDX | 73,03 | -0,08 % | GeneDx: Starkes Wachstum trifft auf schwachen Forderungseinzug | ||
| AVEANNA HEALTHCARE | 12,590 | 0,00 % | Aveanna Healthcare Holdings, Inc. - 8-K, Current Report | ||
| PROGYNY | 25,220 | 0,00 % | Progyny vor dem Boom?: Wells Fargo sieht bei dieser "Kinderwunsch-Aktie" 42 % Kurspotenzial | © Foto: SOPA Images - Sipa USAWells Fargo traut Progyny 42 Prozent Kurspotenzial zu. Das Geschäft mit Kinderwunsch-Leistungen könnte jetzt zum großen Wachstumstreiber werden Enthaltene Werte: US74340E1038Den... ► Artikel lesen | |
| SANARA MEDTECH | 34,860 | +0,03 % | Sanara MedTech Inc. Reports Second Quarter 2026 Financial Results (Unaudited) | FORT WORTH, TX, Aug. 11, 2026 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. ("Sanara," "Sanara MedTech," the "Company," "we," "our" or "us") (Nasdaq: SMTI), a medical technology company focused on developing... ► Artikel lesen |